Moleculary targeted therapy for Myocardial disorders: IL-6 prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 20/July/2014, 7.14 am

Moleculary targeted therapy for Myocardial disorders: IL-6 prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 20/July/2014, 7.14 am

Moleculary targeted therapy for Myocardial disorders: IL-6 prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 20/July/2014, 7.14 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Moleculary targeted therapy for Myocardial disorders:  IL-6 prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 20/July/2014, 7.14 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

 

Share
Start Typing